BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

594 related articles for article (PubMed ID: 9886517)

  • 21. Hormonal implants: contraception for a new century.
    Darney PD
    Am J Obstet Gynecol; 1994 May; 170(5 Pt 2):1536-43. PubMed ID: 8178903
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NORPLANT contraceptive implants advancing.
    Segal SJ
    Netw Res Triangle Park N C; 1984; 5(3):1-3. PubMed ID: 12279797
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessing the acceptability of Norplant contraceptive in four patient populations.
    Dugoff L; Jones OW; Allen-Davis J; Hurst BS; Schlaff WD
    Contraception; 1995 Jul; 52(1):45-9. PubMed ID: 8521714
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characteristics and experiences of American women electing for early removal of contraceptive implants.
    Frank ML; Ditmore JR; Ilegbodu AE; Bateman L; Poindexter AN
    Contraception; 1995 Sep; 52(3):159-65. PubMed ID: 7587187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Irregular bleeding, body mass index and coital frequency in Norplant contraceptive users.
    Pasquale SA; Knuppel RA; Owens AG; Bachmann GA
    Contraception; 1994 Aug; 50(2):109-16. PubMed ID: 7956210
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A five-year evaluation of NORPLANT II implants in China.
    Gu S; Du M; Zhang L; Liu Y; Wang S; Sivin I
    Contraception; 1994 Jul; 50(1):27-34. PubMed ID: 7924320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Continuation rates of long-acting methods of contraception. A comparative study of Norplant implants and intrauterine devices.
    Fleming D; Davie J; Glasier A
    Contraception; 1998 Jan; 57(1):19-21. PubMed ID: 9554246
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of levonorgestrel implants versus oral contraceptives in adolescence: a case-control study.
    Berenson AB; Wiemann CM
    Am J Obstet Gynecol; 1995 Apr; 172(4 Pt 1):1128-35; discussion 1135-7. PubMed ID: 7726249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R; Hales HA; Stevenson K; Hatasaka HH; Poulson AM; Jones KP; Peterson CM
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Levonorgestrel capsule implants in the United States: a 5-year study.
    Sivin I; Mishell DR; Darney P; Wan L; Christ M
    Obstet Gynecol; 1998 Sep; 92(3):337-44. PubMed ID: 9721766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant.
    Zheng SR; Zheng HM; Qian SZ; Sang GW; Kaper RF
    Contraception; 1999 Jul; 60(1):1-8. PubMed ID: 10549446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Menstrual bleeding patterns in Norplant-2 implant users.
    Biswas A; Leong WP; Ratnam SS; Viegas OA
    Contraception; 1996 Aug; 54(2):91-5. PubMed ID: 8842585
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills)--an Indian experience. An ICMR Task Force Study. Indian Council of Medical Research.
    Datey S; Gaur LN; Saxena BN
    Contraception; 1995 Mar; 51(3):155-65. PubMed ID: 7621684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Norplant-2 subdermal contraceptive system: experience in Taiwan.
    Lee TY; Yang YS; Tseng LH; Ko TM; Hsu MC; Chuang SM
    J Formos Med Assoc; 1993 May; 92(5):446-50. PubMed ID: 8104598
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New concepts in contraception: Norplant subdermal implant.
    Lynn MM; Holdcroft C
    Nurse Pract; 1992 Mar; 17(3):85-9. PubMed ID: 1565306
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs.
    Chi IC
    Contraception; 1991 Dec; 44(6):573-88. PubMed ID: 1773615
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Two years of intrauterine contraception with levonorgestrel and with copper: a randomized comparison of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
    Sivin I; Stern J; Diaz J; Diaz MM; Faundes A; el Mahgoub S; Diaz S; Pavez M; Coutinho E; Mattos CE
    Contraception; 1987 Mar; 35(3):245-55. PubMed ID: 3111785
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factors associated with elective Norplant removal in black and white women.
    Opara JU; Ernst FA; Gaskin H; Smith L; Nevels HV
    J Natl Med Assoc; 1997 Apr; 89(4):237-40. PubMed ID: 9145628
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Education and counseling for Norplant users.
    Hinkle LT
    J Obstet Gynecol Neonatal Nurs; 1994 Jun; 23(5):387-91. PubMed ID: 8083779
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM; de Souza JC; da Silva AR; de Acosta OM; Alvarez F; Brache V; Garza Flores J; Vasquez-Estrada L; Santo R; Bassol S
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.